Komori
Ministop (9946) · FactMitigated

Recognition of Costs Related to the Novel Infectious Disease as Extraordinary Losses

First written in FY2021-Q1. 3 of 7 entries say "Mitigated", first in FY2022-Q2. Latest entry: FY2023-Q1.

7entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2021-Q2 – FY2021-Q3MitigatedFY2022-Q2 – FY2023-Q12020: 220202021: 320212022: 22022
Same theme, other companies
Fixed-cost losses from facility closures due to COVID-19A theme 41 companies write about · 41 as a headwind · 0 as a tailwind

16 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 41 companies compared. The sentences above are computed from all 41.
Full recordFilings, disclosures and news, newest first
  1. FY2023-Q1MitigatedAnnual report

    「Losses related to the COVID-19 response　9　－」

    Losses related to the COVID-19 response decreased from ¥9 million in the same period of the previous year to zero in the current quarter.
  2. FY2022-Q3MitigatedAnnual report

    「Losses related to the COVID-19 response　130　24」

    Extraordinary losses related to the COVID-19 response decreased from ¥130 million in the cumulative period of the previous year to ¥24 million.
  3. FY2022-Q2MitigatedAnnual report

    「Losses related to the COVID-19 response　112　18」

    Extraordinary losses related to the COVID-19 response decreased from ¥112 million in the cumulative period of the previous year to ¥18 million.
  4. FY2022-Q1Decrease in infection-control response lossesAnnual report

    「Losses related to the COVID-19 response　92　9」

    Extraordinary losses related to the COVID-19 response decreased from ¥92 million in the same period of the previous year to ¥9 million.
  5. FY2021-Q3AdvancedAnnual report

    「Losses related to the COVID-19 response － 130」

    Recognized ¥130 million in losses related to the COVID-19 response for the first nine months, arising from temporary store closures, reduced operating hours and other measures.
  6. FY2021-Q2AdvancedAnnual report

    「Costs incurred at stores and elsewhere as a result of these measures, including depreciation and rent, have been recognized as extraordinary losses related to the COVID-19 response.」

    Recognized costs associated with temporary store closures and reduced operating hours as losses related to the COVID-19 response, totaling ¥112 million for the first six months of the current fiscal year.
  7. FY2021-Q1First statedAnnual report

    「Accordingly, costs incurred at stores and elsewhere as a result of these measures, including depreciation and rent, have been recognized as extraordinary losses related to the COVID-19 response.」

    Recognized ¥92 million in depreciation, rent and other costs associated with temporary store closures and reduced operating hours as extraordinary losses related to the COVID-19 response.
Moved together

"Enhancing the product assortment to meet everyday needs" moved the same way as this thread, in the same document, in 5 of its 7 moves.

554444★123456
  1. ★This thread
  2. 1Enhancing the product assortment to meet everyday needs5×
  3. 2Evolution of In-Store-Prepared Fast Food5×
  4. 3Planned Scrap-and-Build and a Focus on Profitability4×
  5. 4Expansion of services such as in-store pickup and social gifting4×
  6. 5Integrated Operations with Franchisees and Product Assortment Support4×
  7. 6Sales Promotion Using WAON Electronic Money4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Ministop yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Recognition of Costs Related to the Novel Infectious Disease as Extraordinary Losses | MINISTOP CO.,LTD. (9946) | Komori